Retatrutide: triple GIP/GLP-1/glucagon receptor agonism Retatrutide is an investigational once-weekly triple receptor agonist that activates GIP, GLP-1, and glucagon receptors
Slow reconstitution also reduces mistakes and helps you feel in control
Single dose, pre-filled pens or single dose vials each containing: One 2.5 mg/0.5 mL One 5 mg/0.5 mL One 7.5 mg/0.5 mL One 10 mg/0.5 mL One 12.5 mg/0.5 mL One 15 mg/0.5 mL Multi-dose vial or single-patient-use KwikPen each containing: Four 2.5 mg/0.6 mL doses, Four 5 mg/0.6 mL doses, Four 7.5 mg/0.6 mL doses Four 10 mg/0.6 mL doses Four 12.5 mg/0.6 mL doses Four 15 mg/0.6 mL doses This list may look overwhelming, but your healthcare provider will explain how to measure and administer the correct tirzepatide dosage, depending on which one theyve prescribed
Good storage practices are an important part of therapy with sermorelin, as they help guarantee youre getting the correct dose potency each time
The parallel decline in endogenous GHK-Cu levels is suggestive, though causation has not been established
Picking Your Diluent You've got two options